Dramatic polarization in genitourinary expert opinions regarding the clinical utility of positron emission tomography (PET) imaging in prostate cance
dc.contributor.author | Sandler, Kiri A. | |
dc.contributor.author | McClelland, Shearwood, III | |
dc.contributor.author | Degnin, Catherine | |
dc.contributor.author | Chen, Yiyi | |
dc.contributor.author | Mitin, Timur | |
dc.contributor.department | Radiation Oncology, School of Medicine | en_US |
dc.date.accessioned | 2019-08-08T17:30:06Z | |
dc.date.available | 2019-08-08T17:30:06Z | |
dc.date.issued | 2019-01 | |
dc.description.abstract | OBJECTIVES: To ascertain the opinions of North American genitourinary (GU) experts regarding inclusion of technologies such as prostate - specific membrane antigen (PSMA) and C - 11 choline positron emission tomography (PET) into routine practice. MATERIALS AND METHODS: A survey was distributed to North American GU experts. Questions pertained to the role of PSMA and C - 11 PET in PCa management. Participants were categorized as "supporters" or "opponents" of incorporation of novel imaging techniques. Opinions were correlated with practice patterns. RESULTS: Response rate was 54% and we analyzed 42 radiation oncologist respondents. 17 participants (40%) have been in practice for > 20 years and 38 (90%) practice at an academic center. 24 (57%) were supporters of PSMA and 29 (69%) were supporters of C - 11. Supporters were more likely to treat pelvic nodes (88% vs. 56%, p < 01) and trended to be more likely to treat patients with moderate or extreme hypofractionation (58% vs. 28%, p = 065). Supporters trended to be more likely to offer brachytherapy boost (55% vs. 23%, p = 09), favor initial observation and early salvage over adjuvant radiation (77% vs. 55%, p = 09), and to consider themselves expert brachytherapists (69% vs. 39%, p = 09). CONCLUSIONS: There is a polarization among GU radiation oncology experts regarding novel imaging techniques. A correlation emerged between support of novel imaging and adoption of treatment approaches that are clinically superior or less expensive. Pre - existing biases among GU experts on national treatment - decision panels and leaders of cooperative group studies may affect the design of future studies and influence the adoption of these technologies in clinical practice. | en_US |
dc.identifier.citation | Sandler, K. A., McClelland, S., 3rd , Degnin, C., Chen, Y., & Mitin, T. (2019). Dramatic polarization in genitourinary expert opinions regarding the clinical utility of positron emission tomography (PET) imaging in prostate cancer. International braz j urol : official journal of the Brazilian Society of Urology, 45(1), 23–31. doi:10.1590/S1677-5538.IBJU.2018.0208 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/20254 | |
dc.language.iso | en_US | en_US |
dc.publisher | SciELO | en_US |
dc.relation.isversionof | 10.1590/S1677-5538.IBJU.2018.0208 | en_US |
dc.relation.journal | International braz j urol : official journal of the Brazilian Society of Urology | en_US |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | * |
dc.source | PMC | en_US |
dc.subject | Positron-Emission Tomography | en_US |
dc.subject | Prostatic Neoplasms | en_US |
dc.subject | Radiotherapy | en_US |
dc.title | Dramatic polarization in genitourinary expert opinions regarding the clinical utility of positron emission tomography (PET) imaging in prostate cance | en_US |
dc.type | Article | en_US |